Phase 2a Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Registry ID

EUCTR2020-003887-21

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE2

Sponsor

hVIVO Services Limited

Start date

2020-11-03

Last update

2026-08-16

Conditions

• Respiratory Syncytial Virus Infection

Summary

To evaluate the effect of the RSVpreF vaccine, in reducing the incidence and severity of infection or disease due to RSV-A Memphis 37b when compared to placebo.

Locations

• , , UK

Related clinical trials

• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
• A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
• Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

View on source registry